Tag: ovarian cancer

Drug Boosts Survival for Women With Advanced Ovarian Cancer

By Denise Mann HealthDay Reporter THURSDAY, March 25, 2021 (HealthDay News) — Women with advanced ovarian cancer often face grim statistics, with less than half...

Johnson & Johnson Asks Supreme Court To Void $2 Billion Talc Verdict

WASHINGTON (AP) — Johnson & Johnson is asking for Supreme Court review of a $2 billion verdict in favor of women who claim they developed ovarian cancer...

Why a Diagnosis Often Comes Late

It’s hard to spot ovarian cancer early. The symptoms can mimic other conditions, and there’s a chance you might not have any. What’s more, doctors...

How Patients Decide on Surgery

Patients consider the risk of cancer and menopause, as well as other factors, when making decisions about ovarian cancer prevention surgery, according to a small...

Liquid vs Tissue Biopsy in Prostate Cancer: Why Not Both?

The genomic landscape of circulating tumor DNA (ctDNA) was comparable to the landscape of tissue biopsies in a large study of patients with metastatic castration-resistant...

New Legal Push Aims to Speed Magic Mushrooms to Dying Patients

Erinn Baldeschwiler, mother of Shea McGinnis (left) and Gibson McGinnis, has been diagnosed with stage 4 metastatic breast cancer. Immunotherapy has helped with the physical...

Women Treated for Gynecologic Cancers Skip Doses of Oral Drugs

Oral agents are taking on an ever-greater role in the management of gynecologic cancers. However, women being treated for these cancers have less than ideal...

IVF Won’t Raise Ovarian Cancer Risk: Study

By Robert Preidt HealthDay Reporter THURSDAY, Nov. 19, 2020 (HealthDay News) — Fertility treatments such as in vitro fertilization don’t appear to increase a...

New Technologies Aim to Improve Ovarian Cancer Detection

Encouraging trends abound in the management of ovarian cancer. As rates of ovarian disease continue to decline, there has also been a notable increase in...

A Guide to the New Agents Reshaping Ovarian Cancer Treatment

The treatment of ovarian cancer has evolved considerably in the last few years, with the approval of several PARP inhibitors, antiangiogenic agents, and other therapies...

Two-Stage Surgery to Reduce Ovarian Cancer Risk Piques Interest

“Many physicians would assume that prevention of cancer, especially cancer as serious as ovarian cancer, trumps all other decision making, but when we really listen...

Hair Dye and Cancer Study ‘Offers Some Reassurance’

The largest study of its kind has found no positive association between personal use of permanent hair dye and the risk for most cancers and...

Gene Signature May Improve Prognostication in Ovarian Cancer

A new gene expression signature could improve on conventional risk factors when it comes to estimating prognosis and selecting treatment in patients with high-grade serous...

New Drug for GIST, PARPi for Prostate Cancer

Here are the most important stories that Medscape Oncology‘s editors picked for you to read today. FDA Approves Ripretinib for Advanced GISTs The US Food...

First PARP Inhibitor Approved for Metastatic Prostate Cancer

A completely new approach to the treatment of prostate cancer is now available to clinicians through the approval of the first PARP inhibitor for use...

Olaparib in Ovarian Cancer, Smoking and Lung Cancer

Here are the most important stories that Medscape Oncology’s editors picked for you to read today: A New Era for Ovarian Cancer Olaparib maintenance therapy...

One Strikeout, One Hit Against Low-Grade Serous Carcinomas

Two MEK inhibitors were tested against recurrent low-grade serous carcinomas of the ovaries, fallopian tubes, or peritoneum, but only one inhibitor offered clinical benefit over...

The Challenge of Continuing Clinical Trials

What your doctor is reading on Medscape.com: APRIL 22, 2020 — The impact of COVID-19 on national and international cancer research has been devastating....

Water-Only Fasting May Reduce Chemo Modifications

Patients with gynecologic malignancies who consumed only water for 24 hours before and 24 hours after each chemotherapy cycle had fewer dose delays and reductions...

Younger Gynecologic Cancer Patients at Risk for Early Bone Loss

Younger women treated for uterine or ovarian cancer are at increased risk for decreased bone mineral density and osteoporosis, especially in the first year after...

Financial Toxicity Is Common With Gynecologic Cancers

More than one-fifth of patients being treated for gynecologic malignancies experience financial toxicity, results of a single-center study suggest. Among 5,188 patients treated for gynecologic...

How Long Is It Safe to Delay Gynecologic Cancer Surgery?

What your doctor is reading on Medscape.com: MARCH 27, 2020 — As I write this column, there are more than 25,000 current cases...

Survival & NAC Use Continue to Increase

Uptake of neoadjuvant chemotherapy (NAC) for the treatment of advanced ovarian cancer has increased dramatically since 2006 in the United States, but importantly, the median...